Synthetic Genomics commercializes genomic-driven technologies. The Company's scientific strength lies in the decades of pioneering research by founders J. Craig Venter, PhD, Nobel Laureate Hamilton O. Smith, MD, and the leading scientific teams they have assembled. Dr. Venter and his teams have proven track records of making scientific breakthroughs that translate into viable commercial solutions. The Company's scientific capabilities encompass areas such as environmental genomics, microbiology, biochemistry, bioinformatics, plant genomics, genome engineering, synthetic biology, and climate change.